0001209191-17-039027.txt : 20170609
0001209191-17-039027.hdr.sgml : 20170609
20170609215554
ACCESSION NUMBER: 0001209191-17-039027
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170609
FILED AS OF DATE: 20170609
DATE AS OF CHANGE: 20170609
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: RXi Pharmaceuticals Corp
CENTRAL INDEX KEY: 0001533040
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 257 SIMARANO DRIVE
STREET 2: SUITE 101
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752
BUSINESS PHONE: (508) 767-3861
MAIL ADDRESS:
STREET 1: 257 SIMARANO DRIVE
STREET 2: SUITE 101
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Eliseev Alexey
CENTRAL INDEX KEY: 0001694380
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36304
FILM NUMBER: 17904241
MAIL ADDRESS:
STREET 1: 257 SIMARANO DRIVE, SUITE 101
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-06-09
0
0001533040
RXi Pharmaceuticals Corp
RXII
0001694380
Eliseev Alexey
C/O 257 SIMARANO DRIVE, SUITE 101
MARLBOROUGH
MA
01752
0
1
0
0
Chief Business Officer
Common stock, $0.0001 par value
2017-06-09
4
C
0
332499
A
1150312
D
Series C Convertible Preferred Stock, $0.0001 par value
2017-06-09
4
C
0
332499
0.00
D
Common stock
332499
0
D
The Series C Convertible Preferred Stock automatically converted into common stock upon approval by the Company's stockholders in accordance with the stockholder approval requirements of Nasdaq Marketplace Rule 5635 without payment of consideration. The Series C Convertible Preferred Stock have no expiration.
Caitlin Kontulis, attorney-in-fact
2017-06-09